Sagility India Ltd

Sagility India Ltd

₹ 28.3 -2.89%
21 Nov 4:00 p.m.
About

Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]

Key Points

Market Share [1] Headquartered in Bangalore, the company serves only US customers. It holds 1.23% of the U.S. healthcare outsourcing market as of 2023.

Client Segmentation[2]
- Payers: Health insurance companies that finance and reimburse healthcare services. Sagility provides them with services like claims processing, payment integrity, and clinical management.
- Providers: Hospitals, physicians, and diagnostic centers, with services focused on revenue cycle management (RCM) that includes insurance verification, billing, and accounts receivable follow-up.

  • Market Cap 13,298 Cr.
  • Current Price 28.3
  • High / Low 32.9 / 27.0
  • Stock P/E 58.4
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 4.71 %
  • ROE 3.60 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Debtor days have improved from 183 to 90.7 days.
  • Company's working capital requirements have reduced from 55.0 days to 24.5 days

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Part of BSE IPO

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Jun 2024
1,116 1,223
852 1,029
Operating Profit 264 194
OPM % 24% 16%
11 24
Interest 47 37
Depreciation 166 110
Profit before tax 62 71
Tax % 31% 69%
42 22
EPS in Rs 0.22 0.05
Raw PDF
Upcoming result date: 25 November 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 8m Mar 2023 Mar 2024
923 4,218 4,754
730 3,179 3,665
Operating Profit 193 1,039 1,088
OPM % 21% 25% 23%
18 5 28
Interest 65 215 185
Depreciation 147 644 689
Profit before tax -2 186 242
Tax % 152% 23% 6%
-5 144 228
EPS in Rs -0.02 0.75 0.53
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 54%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Equity Capital 1,919 1,919 4,285
Reserves 2,108 4,288 2,158
4,788 2,896 2,532
1,271 1,427 1,554
Total Liabilities 10,085 10,529 10,529
8,621 8,607 8,667
CWIP 5 0 6
Investments 0 0 0
1,459 1,922 1,856
Total Assets 10,085 10,529 10,529

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
-32 857 973
-7,711 -101 -463
8,116 -545 -751
Net Cash Flow 374 211 -241

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 366 92 91
Inventory Days
Days Payable
Cash Conversion Cycle 366 92 91
Working Capital Days 115 25 25
ROCE % 5% 5%

Shareholding Pattern

Numbers in percentages

Nov 2024
82.39%
6.90%
6.31%
4.40%
No. of Shareholders 1,48,194

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents